CCR4, C-C motif chemokine receptor 4, 1233

N. diseases: 168; N. variants: 1
Disease: Adult T-cell lymphoma/leukaemia recurrent ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0280427
Disease: Adult T-cell lymphoma/leukaemia recurrent
Adult T-cell lymphoma/leukaemia recurrent 		0.010 Biomarker disease BEFREE Mogamulizumab, a defucosylated humanized monoclonal antibody against the C-C chemokine receptor 4 (CCR4), has been approved for the treatment of relapsed adult T-cell leukemia/lymphoma (ATL). 30981611 2019